Literature DB >> 2316432

Risk factors as reflected by an intensive drug monitoring system.

T Jacubeit, D Drisch, E Weber.   

Abstract

Age and gender are often suspected to be risk factors predisposing to ADRs. Therefore the data obtained by the Heidelberg Intensive Drug Monitoring System were analysed for possible correlations between these two variables and the incidence of ADRs. Based on the medical records comprising the time period between 1980 and 1987 information was available on 70,500 admissions to the Heidelberg University Hospital, Department of Medicine. Age, gender, number of prescriptions and ADRs were analysed. The percentage of patients affected by ADRs rises with advancing age; however the number of prescribed drugs also increases. When the incidence of ADRs in various age groups was analysed in relation to prescription data, no effect of age could be found. In contrast there was a linear correlation between the overall incidence of ADRs (independent of age) and the number of prescriptions per patient (per single admission). These results clearly document that age does not seem to be relevant to the incidence of ADRs, but that the risk is related to the number of drugs prescribed to a particular patient.

Entities:  

Mesh:

Year:  1990        PMID: 2316432     DOI: 10.1007/978-3-0348-7292-8_13

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  9 in total

1.  Does age increase the risk of adverse drug reactions?

Authors:  Bernard Bégaud; Karin Martin; Annie Fourrier; Françoise Haramburu
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

2.  Pharmacogenomics of tamoxifen in a nutshell-and who broke the nutcracker?

Authors:  Frankie Ann Holmes; Jeffrey D Liticker
Journal:  J Oncol Pract       Date:  2005-11       Impact factor: 3.840

3.  A drug interactions elective course.

Authors:  Jennifer Trujillo
Journal:  Am J Pharm Educ       Date:  2009-07-10       Impact factor: 2.047

Review 4.  Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantation.

Authors:  Yun R Li; John E Levine; Hakon Hakonarson; Brendan J Keating
Journal:  Eur J Hum Genet       Date:  2013-11-20       Impact factor: 4.246

5.  Patients' perceptions of pharmacist-managed diabetes services in the ambulatory care and community settings within Singapore.

Authors:  Melanie Yee Lee Siaw; Jing Heng Toh; Joyce Yu-Chia Lee
Journal:  Int J Clin Pharm       Date:  2018-01-20

Review 6.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs.

Authors:  Nicholas Moore; Charles Pollack; Paul Butkerait
Journal:  Ther Clin Risk Manag       Date:  2015-07-15       Impact factor: 2.423

8.  Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.

Authors:  John K Darby; David J Pasta; Michael G Wilson; John Herbert
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580

Review 9.  Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development.

Authors:  Bernard Fermini; Shawn T Coyne; Kevin P Coyne
Journal:  SLAS Discov       Date:  2018-06-04       Impact factor: 3.341

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.